- Advertisement -
Tuesday, February 7, 2023

Top 10 Healthcare Diagnostics Solution Providers 2022

Diagnostics are not always perceived as being as exciting or glamorous as therapeutics, but this is a field that is growing and changing just as fast. Rather than simply being a way to identify which patients have a specific disease, diagnostics are now used to support clinical development of drugs, predict disease before symptoms begin, forecast the progress of a disorder, and identify patients who are most likely to respond (or not respond) to specific treatments.

Predictive genetic tests could have substantial benefits to the health outcomes by using a blood, hair, skin or other tissue samples from a person to help predict future risk of disease.6 The potential is enormous, as these tests can identify mutations that increase a person’s risk of developing genetic disorders before any symptoms appear.7 If a medical intervention or preventive measures exist for a predicted disease, then the power of such digital tools becomes extremely useful and even lifesaving.

As a lot of trends are going around the healthcare diagnostics space, healthcare facilities and practitioners find it a tough time to track the right solution provider that exactly fits the unique and changing customer requirements. To help our readers and your prospective clients get a clearer picture of the industry, our panel comprising of CEOs, CTOs and healthcare specialist have developed a list of companies. Listed below are the “Top 10 Healthcare Diagnostics Solution Providers 2022,” who are creating a difference in the industry with their innovative solutions.

BioCoach

Management:

Matt Payne

Designation:

CEO

Headquarters:

Minneapolis, US

Website:

biocoach.io

BioCoach is a medical device startup based out of Minneapolis whose goal is to fight the diabetes pandemic the world is facing. It's a brand built by the people, for the people. BioCoach is a direct-to-consumer in vitro diagnostic testing company whose mission is to make a healthy living simple.

Codetta Biosciences

Management:

TJ Johnson

Designation:

CEO

Headquarters:

Morrisville, NC

Website:

codettabio.com

Codetta Biosciences is a company developing quantitative & digital spatial platforms for nucleic acid & protein assays. A multi-modal, multi-plex, and multi-omics technology company developing a next-generation quantitative and digital spatial platform for nucleic acid and protein assays with unprecedented levels of sensitivity and simultaneous analyte detection from a single specimen.

Co-diagnostics

Management:

Dwight H. Egan

Designation:

CEO

Headquarters:

Salt Lake City, UT

Website:

codiagnostics.com

Co-Diagnostics is a molecular diagnostics company that develops, manufactures, and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

Commonwealth Diagnostics

Management:

Craig S. Strasnick

Designation:

President & CEO

Headquarters:

Salem, MA

Website:

commdx.com

Commonwealth Diagnostics International Inc., (CDI), was founded on the patient-centric principle that early detection and diagnosis of functional gastrointestinal disorders result in expedited treatment, better patient outcomes, and robust cost savings for the healthcare delivery system. CDI offers products and services that aid the diagnosis of small intestinal bacterial overgrowth (SIBO) and irritable bowel syndrome (IBS).

Digital Diagnostics

Management:

Dr. Michael Abramoff

Designation:

Founder & Executive Chairman

Headquarters:

Coralville, US

Website:

digitaldiagnostics.com

Digital Diagnostics, formerly IDx, is a pioneering AI diagnostics company founded with a mission to transform the quality, accessibility, equity, and affordability of healthcare worldwide through the application of technology in the medical diagnosis and treatment process. Founded by Michael Abramoff, MD, PhD, a fellowship-trained retina specialist, neuroscientist, and computer engineer, Digital Diagnostics developed a patented biomarker-based approach to build an autonomous AI platform that makes clinical decisions without human intervention, removing the diagnostic burden of common diseases from specialists.

Elucid

Management:

Todd C. Villines

Designation:

MD

Headquarters:

Boston, MA

Website:

elucid.com

Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, ElucidVivo, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from asingle CTA to inform risk of event (heart attack or stroke) & treatment selection.

Golden Helix

Management:

Andreas Scherer

Designation:

CEO

Headquarters:

Bozeman, MT

Website:

goldenhelix.com

Golden Helix has been delivering industry-leading bioinformatics solutions for the advancement of life science research and translational medicine for over 20 years. their innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from microarrays and next-generation sequencing.

PixCell Medical

Management:

Avishay Bransky

Designation:

Co-Founder & CEO

Headquarters:

HaZafon, Israel

Website:

pixcell-medical.com

PixCell Medical Technologies develops, produces, and markets portable medical diagnostic products for point of care testing. PixCell's products are based on its innovative Viscoelastic Focusing (VEF) technology and single use cartridges that enable rapid, accurate and simple blood sampling and analysis. Results are displayed within minutes in an easily readable format. PixCell's mission is to make tests currently restricted to the laboratory more accessible, easy to use and affordable.

renegade.bio

Management:

Craig Rouskey

Designation:

Co-Founder & CEO

Headquarters:

San Francisco, CA

Website:

renegade.bio

Renegade. bio provides rapid and cost-effective diagnostic testing for the detection of novel infectious diseases. The company develop diagnostics that identify disease earlier, faster, and more affordably. It also create diagnostics in-house, as well as with biotech partners who are also pushing for radically improved health outcomes.

Techcyte

Management:

Ben Cahoon

Designation:

CEO

Headquarters:

Orem, UT

Website:

techcyte.com

Techcyte is a cloud-based, SaaS provider that provides the world's leading clinical digital pathology platform that uses deep learning image analysis to help labs and clinics become more efficient and accurate. The platform is HIPAA compliant, CE marked and supports tests across hematology, cytology, bacteriology, and parasitology. Techcyte has solutions for human, veterinary, and environmental clinics and labs.